genetics

Epigenetic profiling creates opportunities for healthcare and the development of new drugs based on it, according to Mohamad Takwa, CEO of Epigenica, a Sweden-based company that focuses on the technology.

Joel Diamond, MD, CMO of 2bPrecise, discusses pharmacogenomics as a good entry point for providers in precision medicine, identifying the right medicine for better outcomes and patient satisfaction.

Erin Trimble of 23andMe touches on the value of polygenic risk scores, how to use genetic information to improve health and the importance of equipping primary care providers to talk with their patients about genetics.